Edinburgh researchers and LifeArc to boost MND treatment processes
Partnership will establish drug candidates using both laboratory tests and machine-learning
Read More
Tag: MND
Clinigen’s ALS therapy bags US orphan status
Clinigen has bagged a US orphan drug designation (ODD) for its investigational Amyotrophic Lateral Sclerosis (ALS) treatment aldesleukin.
Read More
Experimental motor neurone disease therapy shows early promise
Phase I/II study results demonstrate proof-of-concept and proof-of-biology of tofersen
Read More
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
